Ukraine has registered a vaccine against coronavirus (COVID-19) Janssen manufactured by Johnson & Johnson.
According to the Center for Public Health and the Health Ministry, the vaccine was registered for emergency medical use on July 2.
At the same time, it is specified that one dose of Janssen vaccine is sufficient for complete immunization.
The vaccine is approved for emergency use by WHO. The United States, Great Britain, the European Union, Switzerland, Canada and other countries have also given permission to use it.
This is a vector vaccine developed by Janssen, owned by Johnson&Johnson. It requires a storage temperature from minus two to plus eight degrees Celsius.
© 2016-2025, Open4Business. All rights reserved.
All news and diagrams placed on this Web site is made for internal use. Its reproduction or distribution in any form are welcome in case of placing a direct hyperlink to a source. Reproduction or distribution of information which contains Interfax-Ukraine as a source is prohibited without the written permission from the Interfax-Ukraine news agency. Photoes placed on this site are taken from open sources only; rightholder are welcome to make demands to info@open4business.com.ua , in this case we are ready to put your copyright to a photo or replace it.